Total Payments
$662,344
2024 Payments
$23,920
Companies
51
Transactions
1,688
Medicare Patients
1,755
Medicare Billing
$470,477
Payment Breakdown by Category
Other$543,997 (82.1%)
Travel$54,710 (8.3%)
Consulting$32,518 (4.9%)
Food & Beverage$31,078 (4.7%)
Education$41.69 (0.0%)
Gifts$0.75 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $540,911 | 261 | 81.7% |
| Travel and Lodging | $54,710 | 155 | 8.3% |
| Consulting Fee | $32,518 | 12 | 4.9% |
| Food and Beverage | $31,078 | 1,247 | 4.7% |
| Honoraria | $3,000 | 1 | 0.5% |
| Grant | $85.45 | 2 | 0.0% |
| Education | $41.69 | 9 | 0.0% |
| Gift | $0.75 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $210,494 | 348 | $0 (2024) |
| ABBVIE INC. | $159,242 | 282 | $0 (2024) |
| Lilly USA, LLC | $67,468 | 123 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $60,540 | 153 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $58,570 | 70 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $39,627 | 106 | $0 (2020) |
| Allergan, Inc. | $25,222 | 89 | $0 (2022) |
| IMPEL PHARMACEUTICALS INC. | $22,688 | 37 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $4,238 | 53 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $3,832 | 21 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,920 | 116 | ABBVIE INC. ($21,945) |
| 2023 | $72,354 | 205 | ABBVIE INC. ($64,530) |
| 2022 | $102,885 | 216 | ABBVIE INC. ($40,281) |
| 2021 | $129,019 | 225 | Biohaven Pharmaceuticals, Inc. ($58,570) |
| 2020 | $67,737 | 159 | Amgen Inc. ($26,574) |
| 2019 | $113,475 | 330 | Amgen Inc. ($67,962) |
| 2018 | $105,333 | 264 | Amgen Inc. ($86,789) |
| 2017 | $47,621 | 173 | Supernus Pharmaceuticals, Inc. ($28,418) |
All Payment Transactions
1,688 individual payment records from CMS Open Payments — Page 1 of 68
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Tonix Medicines, Inc. | ZEMBRACE SYMTOUCH (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: PAIN | ||||||
| 11/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Neuroscience | ||||||
| 11/20/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: PAIN | ||||||
| 11/14/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: PAIN | ||||||
| 11/11/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/23/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Neuroscience | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/15/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $25.69 | General |
| Category: NEUROLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/04/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: PAIN | ||||||
| 10/01/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: PAIN | ||||||
| 09/23/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Insomnia | ||||||
| 09/19/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Neuroscience | ||||||
| 09/17/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.44 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 455 | 17,740 | $324,607 | $126,720 |
| 2022 | 10 | 470 | 20,294 | $363,791 | $138,167 |
| 2021 | 10 | 500 | 19,617 | $375,821 | $140,995 |
| 2020 | 8 | 330 | 8,326 | $148,747 | $64,596 |
Total Patients
1,755
Total Services
65,977
Medicare Billing
$470,477
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 30 | 16,902 | $139,442 | $83,977 | 60.2% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 28 | 79 | $33,180 | $8,016 | 24.2% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 140 | 325 | $40,336 | $8,004 | 19.8% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 14 | 48 | $17,891 | $6,888 | 38.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 54 | $26,568 | $5,731 | 21.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 77 | $19,014 | $3,822 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 46 | $16,171 | $2,900 | 17.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 56 | 96 | $14,714 | $2,871 | 19.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $10,812 | $2,712 | 25.1% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 20 | 59 | $5,091 | $1,425 | 28.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 36 | $1,390 | $372.42 | 26.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 33 | 19,400 | $160,050 | $95,014 | 59.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 120 | $42,185 | $9,117 | 21.6% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 30 | 87 | $36,540 | $8,988 | 24.6% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2022 | 127 | 345 | $42,818 | $8,018 | 18.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 42 | 67 | $32,964 | $6,329 | 19.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 106 | $26,175 | $5,221 | 19.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 49 | 67 | $10,269 | $2,051 | 20.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $6,607 | $1,754 | 26.5% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 23 | 56 | $4,832 | $1,292 | 26.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 35 | $1,351 | $382.66 | 28.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 35 | 18,704 | $154,308 | $90,838 | 58.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 84 | 172 | $60,465 | $13,880 | 23.0% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 34 | 94 | $39,480 | $10,565 | 26.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 49 | 73 | $36,025 | $6,930 | 19.2% |
About Dr. Kevin Kahn, MD
Dr. Kevin Kahn, MD is a Neurology healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013088350.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Kahn, MD has received a total of $662,344 in payments from pharmaceutical and medical device companies, with $23,920 received in 2024. These payments were reported across 1,688 transactions from 51 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($540,911).
As a Medicare-enrolled provider, Kahn has provided services to 1,755 Medicare beneficiaries, totaling 65,977 services with total Medicare billing of $470,477. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Durham, NC
- Active Since 11/10/2006
- Last Updated 07/21/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1013088350
Products in Payments
- Aimovig (Biological) $173,934
- UBRELVY (Drug) $96,175
- QULIPTA (Drug) $86,417
- NURTEC ODT (Drug) $63,013
- EMGALITY (Drug) $54,113
- TROKENDI XR (Drug) $39,623
- AJOVY (Biological) $37,799
- Trudhesa (Drug) $22,688
- AJOVY (Drug) $18,969
- ONZETRA Xsail (Drug) $3,824
- ELYXYB - CELECOXIB (Drug) $3,000
- BOTOX (Biological) $1,708
- VYEPTI (Biological) $744.62
- NUEDEXTA (Drug) $532.42
- QUDEXY XR Topiramate Extended Release Capsules (Drug) $499.17
- MIGRANAL (Drug) $412.90
- Horizant (Drug) $350.75
- ZOMIG (Drug) $286.14
- SPRIX (Drug) $279.11
- TOSYMRA SUMATRIPTAN NASAL SPRAY (Drug) $266.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Durham
Mark Skeen, M.d, M.D
Neurology — Payments: $770,195
Neurology $770,195
Dr. Alan Finkel, Md, MD
Neurology — Payments: $405,703
Neurology $405,703
Natalia Gonzalez, Md, MD
Neurology — Payments: $219,812
Neurology $219,812
Dr. Anne Calhoun, Md, MD
Neurology — Payments: $203,020
Neurology $203,020
Dr. Jeffrey Guptill, M.d, M.D
Neurology — Payments: $191,526
Neurology $191,526
Dr. Aatif Husain, M.d, M.D
Neurology — Payments: $185,344
Neurology $185,344